Transitional cell carcinoma cystoscopy and bladder biopsy: Difference between revisions

Jump to navigation Jump to search
 
Line 6: Line 6:


==Cystoscopy and Biopsy==
==Cystoscopy and Biopsy==
* If the initial TURBT identifies muscle invasive (T2) disease, definitive therapy is generally indicated.
* Cystectomy may also play a role in the management of patients with non-muscle invasive bladder cancer.
* Any of the following represents a strong indication to proceed to cystectomy:
* T1 tumors with lymphovascular invasion
* Variant histologies, including micropapillary transitional cell carcinoma, sarcoma, squamous cell carcinoma, or adenocarcinomas
* T1, grade 3 tumors that were incompletely resected
* Prostatic duct/acinar CIS
* Relative indications :
* Ta or T1 high-grade plus CIS; T1b tumors (ie, deep involvement of lamina propria)
* Persistent T1, grade 3 tumors identified on reresection
* Recurrent or persistent disease within 6 to 12 months of initiating treatment with BCG
* Large-volume Ta, low-grade disease
* Women with bladder neck and/or urethra CIS
* However, decisions regarding cystectomy should be individualized based on the surgical risks of the patient.


*Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.
*Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.

Latest revision as of 18:34, 4 October 2019

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma cystoscopy and bladder biopsy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma cystoscopy and bladder biopsy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma cystoscopy and bladder biopsy

CDC on Transitional cell carcinoma cystoscopy and bladder biopsy

Transitional cell carcinoma cystoscopy and bladder biopsy in the news

Blogs on Transitional cell carcinoma cystoscopy and bladder biopsy

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma cystoscopy and bladder biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.

Cystoscopy and Biopsy

  • Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.
  • Cystoscopy may be performed to do biopsy
  • Cystoscopy is the gold standard for surveillance in patients with a history of bladder cancer
  • To view histopathologic characteristic features of all transitional cell carcinoma, click here

References

Template:WH Template:WS